Genomics

Dataset Information

0

The ISR activation confers vulnerability to mitoribosome-targeting antibiotics in melanoma

ABSTRACT: The ISR activation confers vulnerability to mitoribosome-targeting antibiotics in melanoma

PROVIDER: PRJNA737120 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR14794200.fastq.gz Fastqsanger.gz
SRR14794201.fastq.gz Fastqsanger.gz
SRR14794202.fastq.gz Fastqsanger.gz
SRR14794203.fastq.gz Fastqsanger.gz
SRR14794204.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 88

Similar Datasets

Other The ISR activation confers vulnerability to mitoribosome-targeting antibiotics in melanoma
2021-07-15 | GSE177075 | GEO
Genomics Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists
| PRJNA506248 | ENA
Genomics Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists [C790 cells]
| PRJNA504897 | ENA
Genomics Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists [4434 cells]
| PRJNA504899 | ENA
Genomics Persister state-directed transitioning and vulnerability in melanoma
| PRJNA485951 | ENA
Genomics Persister state-directed transitioning and vulnerability in melanoma
| PRJNA574414 | ENA
Genomics Persister state-directed transitioning and vulnerability in melanoma
| PRJNA706426 | ENA
Genomics Lipid droplets are a metabolic vulnerability in melanoma
| PRJNA831276 | ENA
Transcriptomics Lipid droplets are a metabolic vulnerability in melanoma
2023-03-26 | GSE201378 | GEO
Proteomics Selective abrogation of S6K2 maps lipid homeostasis as a survival vulnerability in MAPKi-resistant NRAS-mut melanoma
2019-02-25 | MSV000083480 | MassIVE